Garth Phibbs, M.D., FACOG

Toledo, Ohio 43606

0 studies enrolling now · 2 studies all time

What they study most

Ovarian Neoplasms

Studies at this site

• Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer — Stopped early
• TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer — Completed